Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease
Author(s): William Herrington Added: 1 year ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
An Expert Approach to Cardio-Renal Protection in CKD: Part One
Author(s): Navdeep Tangri , James Burton , David Wheeler Added: 1 year ago
Part one of this two-part programme focuses on our current guideline-directed approach to chronic kidney disease (CKD) and how SGLT-2 inhibitors can be used to maximal effect. Chaired by Prof James Burton (University of Leicester, UK), this roundtable features expert insight from a world-renowned faculty, Prof David Wheeler (University College London, UK), Dr Navdeep Tangri (University of… View more

Heart Failure

Prevention & Chronic Conditions
An Expert Approach to Cardio-Renal Protection in CKD: Part Two
Author(s): James Burton Added: 1 year ago
Chaired by Prof James Burton (University of Leicester, UK), this roundtable features expert insight from a world-renowned faculty, Prof David Wheeler (University College London, UK) and Dr Navdeep Tangri (University of Manitoba, CA).Dr Tangri begins by providing an overview of the recent KDIGO guideline updates. Following this, the panel recap on the patient case that was presented in part one of… View more

Heart Failure

Prevention & Chronic Conditions
Importance of Testing for CKD Among Patients With Type 2 Diabetes
Author(s): Pam Taub , Nikolaus Marx Added: 1 year ago
RP-UN-CAR-GB-0166 / June 2024This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical… View more

Guidelines & Statements

Prevention & Chronic Conditions
ERA 23: REVEAL-CKD: Underdiagnosis of CKD
Author(s): Navdeep Tangri Added: 2 years ago
ERA 23 - In this short video from ERA 23, we are joined by Dr Navdeep Tangri (Max Rady College of Medicine, Manitoba, CA) to discuss the findings from the REVEAL-CKD Trial. REVEAL-CKD is a retrospective, multinational, non-interventional, observational study which aimed to investigate the prevalence and consequences of undiagnosed chronic kidney disease (CKD) in a cohort of 670000 participants. … View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
ESC 24: FINE-HEART: Finerenone in HF & CKD
Author(s): Muthiah Vaduganathan Added: 1 year ago
ESC Congress 2024 — Finerenone improved outcomes in two trials in patients with CKD with T2D, and in patients with HFmrEF and HFpEF.Investigator, Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) joins us in London to discuss the findings from the FINE-HEART pooled analysis (Bayer).FINE-HEART is a pre-specified, exploratory pooled analysis combining data from three phase III clinical… View more

Heart Failure

Prevention & Chronic Conditions
An Expert Approach to Cardio-Renal Protection in CKD: Part One
Author(s): James Burton, David Wheeler, Carol Pollock ,et al Start date: Mar 11, 2024

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
An Expert Approach to Cardio-Renal Protection in CKD: Part Two
Author(s): James Burton, David Wheeler, Carol Pollock ,et al Start date: Apr 18, 2024

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Added: 7 months ago Source:  Radcliffe CVRM
AUTHOR: Liam ONeillWhile elevated systolic blood pressure variability (SBPV) is a known risk factor for adverse health outcomes, new research published in the European Heart Journal suggests that the change in SBPV over time is also a critical prognostic indicator. The study found that an increase in visit-to-visit SBPV over a 10-year period was significantly associated with a higher risk of… View more

Cardiovascular Renal Metabolic

Heart Failure
Obesity in Focus: Implications for Heart Failure, Kidney Disease, and Pharmacology
Author(s): Chim C Lang , Bianca Rocca , Samira Bell Added: 5 months ago
In this short discussion, join Prof Chim Lang (University of Dundee, Dundee, UK), Guest Editor of the upcoming Special Focus on Obesity in Focus, Prof Bianca Rocca (LUM University, Casamassima, IT) and Dr Samira Bell (University of Dundee, Dundee, UK) to discover the implications of obesity on heart failure, kidney disease, and pharmacology.This conversation sets the stage for the upcoming… View more

Cardiovascular Renal Metabolic

Heart Failure